ClinicalTrials.Veeva

Menu

Exploring the Role of Magnesium in Rest Cramps

University of British Columbia logo

University of British Columbia

Status

Completed

Conditions

Rest Cramps

Treatments

Drug: Intravenous Infusion of Magnesium Sulfate

Study type

Interventional

Funder types

Other

Identifiers

NCT00423540
Health Canada #9427-R1243-21C
H06-03345

Details and patient eligibility

About

This study sets out to show whether infusions of magnesium can lessen the frequency of rest cramps and to determine whether rest cramp sufferers have a deficiency in magnesium.

Full description

Subjects will be randomized to receive 5 days of 4 hour IV infusions of D5W either with or without 20 mmol magnesium sulfate added. Twenty four hour urinary excretion of magnesium will be determined on the first day of infusions to assess whether magnesium deficiency is present. Ten normal controls will also undergo a single infusion and collection of urine to serve as a comparison group for the urinary excretion data.

Enrollment

54 estimated patients

Sex

All

Ages

19+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • ≥2 leg or foot cramps per week in a 4 week run-in diary

Exclusion criteria

  • eGFR<50
  • Neurologic disease
  • Pregnancy
  • Heart block
  • Bradyarhythmia without pacemaker
  • Digoxin use
  • Liver disease
  • Addison's disease
  • History of MI
  • CHF
  • Absence of detectable reflexes

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems